Measles vaccine field trials in Alaska. 3. Two-year follow-up of inactivated vaccine followed by live, attenuated vaccine and of immune globulin with live, attenuated vaccine.
D002648:Child; D002675:Child, Preschool; D006801:Humans; D008457:Measles / Q000517:prevention & control*; D008458:Measles Vaccine; D012712:Serum Globulins / Q000627:therapeutic use*
D008458:Measles Vaccine; D012712:Serum Globulins